Welcome to our dedicated page for Delixy Holdings Ltd. news (Ticker: DLXY), a resource for investors and traders seeking the latest updates and insights on Delixy Holdings Ltd. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Delixy Holdings Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Delixy Holdings Ltd.'s position in the market.
Delixy Holdings Limited (Nasdaq: DLXY), a Singapore-based oil products trading company, has successfully completed its Initial Public Offering (IPO). The company offered 2,000,000 ordinary shares at $4.00 per share, raising total gross proceeds of $8 million.
The offering consisted of 1,350,000 shares from the company and 650,000 shares from selling shareholders. Delixy received $5.4 million in gross proceeds before expenses. Trading began on the Nasdaq Capital Market on July 9, 2025. The company plans to use the proceeds for expanding product offerings, strengthening market position, potential strategic acquisitions, and general working capital.
Delixy Holdings Limited (NASDAQ:DLXY), a Singapore-based oil products trading company, has announced the pricing of its initial public offering at $4.00 per share. The IPO consists of 2,000,000 ordinary shares, with 1,350,000 shares offered by the company and 650,000 by selling shareholders.
The company expects to raise gross proceeds of $5.4 million from the offering, which will be used for expanding product offerings, strengthening market position, potential strategic acquisitions, and general working capital. Trading is set to commence on July 9, 2025, on the Nasdaq Capital Market under the symbol "DLXY". The offering is expected to close around July 10, 2025, with Bancroft Capital, LLC serving as the sole lead underwriter.
FAQ
What is the current stock price of Delixy Holdings Ltd. (DLXY)?
